National Institutes of Health
Early to Definitive Clinical Trials (R61/R33 Clinical Trial Required)
Early to Definitive Clinical Trials (R61/R33 Clinical Trial Required) is a funding opportunity from National Institutes of Health, closing July 31, 2027.
Overview
The National Institutes of Health (NIH) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications that propose early to definitive clinical trials. Trials testing drugs, devices, biologics, procedures, behavioral, social, economic, health services, or other biomedical or…